On a per-share basis, the
The drugmaker posted revenue of
For the year, the company reported that its loss narrowed to
Acorda shares have climbed 64% since the beginning of the year. In the final minutes of trading on Thursday, shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source